ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
9.59
-0.28 (-2.89%)
Jun 5, 2026, 12:10 PM EDT - Market open
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or -2.67% compared to the previous year.
Employees
73
Change
-2
Growth
-2.67%
Revenue / Employee
$410,059
Profits / Employee
-$7,471
Market Cap
86.71M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| MindWalk Holdings | 102 |
| Pelthos Therapeutics | 92 |
| Fortress Biotech | 78 |
| Rani Therapeutics Holdings | 71 |
| Aardvark Therapeutics | 40 |
| Atara Biotherapeutics | 14 |
| MAIA Biotechnology | 13 |
ICCC News
- 21 days ago - ImmuCell Earnings Call Transcript: Q1 2026 - Transcripts
- 21 days ago - ImmuCell Quarterly report: Q1 2026 - Filings
- 21 days ago - ImmuCell Earnings release: Q1 2026 - Filings
- 21 days ago - ImmuCell Slides: Q1 2026 - Filings
- 21 days ago - ImmuCell Slides: Investor presentation - Filings
- 21 days ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 - GlobeNewsWire
- 4 weeks ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 - GlobeNewsWire
- 6 weeks ago - ImmuCell Proxy statement: Proxy filing - Filings